Loading ...
the myocardiumleadingto a reduced ejection fraction
ischemic heart disease(passive) caused byreduced ejection fraction
the so - called congestive heart failurecauseslow ejection fraction
Ejection Fraction Analysis of FactorsCan InfluenceEjection Fraction
coronary artery disease[1(passive) is ... caused byreduced ejection fraction ( HFrEF
heart ratesettingEjection fraction
Thioridazine is usedto preventasianew reduced ejection fraction entresto
the ventricle usu- allycausinga decrease in ejection fraction
ongoing damage to the heart due to small or blocked arteries ( coronary artery disease(passive) caused bya decreased ejection fraction
One or more heart attackscan causea decrease in the ejection fraction
The reason ... the heart musclecausesreduced ejection fraction
active coronary artery disease , long - standing hypertension , viral infections and valvular disease(passive) may be caused byLow Ejection fraction
abnormalities of their systolic function just not severe enoughto causereduction in ejection fraction
Effects of stress on global left ventricular function Treadmill exerciseledto a reduction in ejection fraction
opening and closure of the aortic and mitral valves ... abnormal diastolic functioncan resultin reduced ejection fraction
Damage to the heart 's muscle — from a heart attack , heart muscle disease ( such as cardiomyopathy ) , or other causescan leadto a lower ejection fraction
right ventricular dysfunctionleadingto decreased ejection fraction
Both external and internal pacingcauseda reduction in ejection fraction
a reduction in the SVresultingin decreased ejection fraction
the contractile efficiencyleadingto reduction in ejection fraction
The lack of contractile augmentation was partly compensated for by increased RV dilationleadingto a slightly reduced ejection fraction
In 12 female rabbits , CHF was induced by 4 weeks of rapid ventricular pacingleadingto a decrease in ejection fraction
dilated cardiomyopathy with complete restoration of LVEF(passive) caused byreduced ejection fraction
response to TACresultingin decreased ejection fraction
The devil is in the details;LBBB in its own rightcan causea reduction in ejection fraction
dysynchronycan causea decrease in the ejection fraction
Inspiratory threshold loadingcausedan inspiratory decrease in ejection fraction
brief periods of increased density in the arms of the collecting systemleadingto reductions in ejection fraction
I / R injury(passive) caused byejection fraction
excessive afterloadhas ... causeda reduction in ejection fraction
an increased left ventricular end - systolic volume(passive) is mainly caused byThe reduced ejection fraction
Poor left ventricle contractionleadsto reduced ejection fraction
dyssynchronycausinga lowered ejection fraction
IV cordaronecauseda decrease in the ejection fraction
systolic and diastolic volumes ... hypertrophy ( Figure 3resultedin a reduction in ejection fraction
respiratory - induced intrathoracic pressure changes during normal free breathing(passive) caused byejection fraction
several things(passive) can be caused byA decrease in ejection fraction
All this because the man had atrial fibrillationledto a lower ejection fraction
may not be sufficiently extensiveto causea decrease in ejection fraction
The only way I know of HAPEcausinga lowered ejection fraction
to systolic heart failureleadsto systolic heart failure
congestive heart failurecausingcongestive heart failure
to heart failure ( 1finally leadingto heart failure ( 1
to chronic hypoxia , which causes extreme fatigue and weaknesscan leadto chronic hypoxia , which causes extreme fatigue and weakness
alsocontributesalso
a heart murmurmay causea heart murmur
from ischemic heart diseaseresultingfrom ischemic heart disease
pharmacologic stress on the heartCausespharmacologic stress on the heart
to a buildup of volume in the left heart and pulmonary circulationleadingto a buildup of volume in the left heart and pulmonary circulation
in the heart squeezing little blood out into the circulation with each pumpresultingin the heart squeezing little blood out into the circulation with each pump
to fatigue , abdominal pain , inability to exercise and irregular heartbeatcan leadto fatigue , abdominal pain , inability to exercise and irregular heartbeat
it may mean that I 'm done with my herceptin treatments ( sigh ) so that we do n't damage my heart inadvertently by making it pump harder and enlarging one side of my heartwas causingit may mean that I 'm done with my herceptin treatments ( sigh ) so that we do n't damage my heart inadvertently by making it pump harder and enlarging one side of my heart
to a further reduction in HRV ( p<0.01leadsto a further reduction in HRV ( p<0.01
to improved LV function in 15-epi - LXA4 treated mice post - MIleadingto improved LV function in 15-epi - LXA4 treated mice post - MI
to a less than 50 % left ventricular ejectionresultingto a less than 50 % left ventricular ejection
shortness of breathoften causesshortness of breath
to reduced cardiac outputleadsto reduced cardiac output
in low cardiac output contributing to the crashresultingin low cardiac output contributing to the crash
many cases(passive) caused bymany cases
to decreased blood flow at the time of high demand ( as in increased physical activityleadsto decreased blood flow at the time of high demand ( as in increased physical activity
from , e.g. , increased afterload in the dexamethasone - treated animalsresultsfrom , e.g. , increased afterload in the dexamethasone - treated animals
to renal hypoperfusion and then lead to kidney dysfunctionwill leadto renal hypoperfusion and then lead to kidney dysfunction
to increase both myocardial contractility and relaxationis designedto increase both myocardial contractility and relaxation
to easy fatigabilityleadingto easy fatigability
from long - standing severe aortic insufficiencyresultingfrom long - standing severe aortic insufficiency
a 60 to 75 percentsettinga 60 to 75 percent
to deathcan leadto death
treatment discontinuation in everolimus - treated patients and one in the placebo groupcausedtreatment discontinuation in everolimus - treated patients and one in the placebo group
ischemiacauseischemia
to episodes of arrhythmia , progressive pump failureleadingto episodes of arrhythmia , progressive pump failure
to decompensation , valvular damage , or worse arrhythmias.6leadingto decompensation , valvular damage , or worse arrhythmias.6
to abdominal discomfort and painmay leadto abdominal discomfort and pain
to trastuzumab interruptionleadingto trastuzumab interruption
to 33 , 45 , and 60 %setto 33 , 45 , and 60 %
the risk of rehospitalization ( P=0.035influencedthe risk of rehospitalization ( P=0.035
from therapy with nonglycosidic positive inotropic agentsresultingfrom therapy with nonglycosidic positive inotropic agents
topamaxdoes ... causetopamax
in better survival rateresultingin better survival rate
in systolic dysfunction as compared to SHHF(+/resultingin systolic dysfunction as compared to SHHF(+/
the hemodynamic consequences of arrhythmias , both supraventricular and ventricularmay influencethe hemodynamic consequences of arrhythmias , both supraventricular and ventricular